Evaluation of motor impulsivity in Huntington Disease with a choice reaction time task and brain metabolic (PET 18FDG) imaging
Objective: To describe motor impulsivity in early Huntington disease (HD) with electromyographic (EMG) recordings during a choice reaction time task (Simon Task) and brain metabolic…Accessing Speech and Language Therapy (SLT) in a Multi-Disciplinary Movement Disorders Clinic (MDC)
Objective: To enable access to SLT for patients with Parkinson’s (PwP) in the MDC at the Royal Berkshire Hospital (RBH). Background: A successful bid in…Models of Parkinson’s disease in vitro
Objective: The problem for experimental studies of the pathogenesis of Parkinson's disease is the impossibility of taking material from patients with this pathology, therefore, it…Falls in people with Parkinson’s disease: Results from a Multidisciplinary Movement Disorders Clinic in Singapore
Objective: To investigate the prevalence of falls in patients with Parkinson’s disease (PD) and their associations with age, disease stage, gait freezing and speed, postural…Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?
Objective: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy? Background: Increased serum titers of antiGAD antibody can be seen…Parkinson’s disease, peripheral neuropathy, impaired gait, and the role of physiotherapy
Objective: Sensory system is impaired in PN. Sensory impairment can affect balance. PD patients have impaired balance. Thus, PD patients with PN are more likely…Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism
Objective: The aim of the work is to analyze whether combined examination of the frontal lobe using single photon emission computer tomography (SPECT) and Frontal…The characteristic of gait in progressive progressive supranuclear palsy
Objective: To elucidate the characteristic of gait in patients with progressive supranuclear palsy (PSP) and compare to healthy elderly and patients with Parkinson’s disease (PD)…Nilotinib for treating MSA: A preclinical proof of concept study
Objective: To assess the effects of nilotinib on motor behavior, α-synuclein burden and surrogate markers of neurodegeneration in a transgenic mouse model of multiple system…Expanding the NINDS Parkinson’s Disease Biomarkers Program – Utilizing a Major Biomarker Resource to Address Atypical Parkinsonisms and Related Conditions
Objective: Expansion of a carefully curated resource for clinical and biosample data to address a critical need for biomarker discovery in Atypical Parkinsonisms and related…
- « Previous Page
- 1
- …
- 130
- 131
- 132
- 133
- 134
- …
- 177
- Next Page »